Furthermore, the inhibition of NRF2 in ALDH+ OC cells and CD44+ BC cells has demonstrated a reduction in CSC properties, including chemoresistance, tumor growth, and spheroid formation [233]. This evidence concerns the gene CD44 and breast cancer.